Jiangsu Hengrui Pharmaceuticals Co., Ltd. (Hengrui Pharma) is an innovative, global pharmaceutical company dedicated to the research, development and commercialization of high-quality medicines to address unmet clinical needs. With a global R&D team that includes 14 R&D centers and more than 5,500 professionals, Hengrui Pharma’s therapeutic areas of focus include oncology, metabolic and cardiovascular diseases, immunological and respiratory diseases, and neuroscience. To date, Hengrui has commercialized 19 new molecular entity drugs and 4 other innovative drugs in China. Founded in 1970 with the core principle of putting patients first, Hengrui Pharma remains committed to advancing human health by striving to conquer diseases, improve health, and extend lives through the power of science and technology.
Company Details
- Employees
- 3.54K
- Address
- Pudong New Area, Shanghai, China, No. 1288,haike Road,china
- Industry
- Pharmaceutical Manufacturing
- NAICS
-
Pharmaceutical and Medicine ManufacturingMedicinal and Botanical ManufacturingPharmaceutical Preparation ManufacturingIn-Vitro Diagnostic Substance ManufacturingBiological Product (except Diagnostic) Manufacturing
- Website
- hrs.com.cn
- HQ
- Shanghai, Shanghai
Hengrui Pharma Questions
Hengrui Pharma's website is hrs.com.cn
Hengrui Pharma's LinkedIn profile is https://cn.linkedin.com/company/hengrui-pharma
Hengrui Pharma has
3.54K employees.
View email and phone details for 3.54K
employees at Hengrui Pharma.
Hengrui Pharma's industry is
Pharmaceutical Manufacturing
Hengrui Pharma's top competitors are
Beigene,
Astrazeneca,
Bristol Myers Squibb,
Fosun Pharma,
Sino Biopharmaceutical Limited,
Eli Lilly And Company,
Kailera Therapeutics,
Hengrui Usa,
Cspc Pharmaceutical Group,
Innovent Biologics.
Hengrui Pharma's categories are Pharmaceutical Manufacturing
